搜索新闻
媒体联系

电子邮箱:id201@e-techco.com

联系电话:86-755-83209797

瑞士银行视察易特科(前海安测)智慧医疗

日期:2018-12-28 来源:易特科 浏览次数190396

2018年12月28日,瑞士银行副董事邹星澄先生率领核心团队一行多人莅临易特科(前海安测)深圳总部实地视察AI医疗创新项目,交流医疗信息化和医疗大数据应用。易特科(前海安测)董事长兼CEO张贯京先生,副董事长兼MD肖应芬女士,CTO葛新科博士,总工程师兼投资部总经理高伟明博士,副总工程师张红治博士,投资部副总经理任文栋先生,高级售前经理付文正先生、赵康府先生等核心团队全程陪同视察,并向邹总及其团队详细讲解了易特科(前海安测)AI医疗项目建设情况和进度。


邹董一行专心致志地参观了易特科集团产品展示区,了解了诺奖科学家Edvard I. Moser教授和Craig C. Mello教授主导的“智慧医疗诺奖实验室”研究项目,仔细咨询了易特科(前海安测)健康化、智能化、高端化医疗大健康建设情况,饶有兴致地体验了安测健康智能一体机、安测中医四诊仪等信息化产品,自助体检血压、血糖、心电等项目。




现场体验完产品和服务后,考察团一行对易特科集团在医疗大健康领域的的规划布局、研发创新等方面表示高度认可,肯定了项目人员在研发、创新方面精益求精的工作态度。



座谈期间,张贯京董事长提到,易特科集团在各大银行系统和金融机构的支持下,生产经营、品牌塑造、智能化升级、AI医疗项目建设等均全面推进,发展稳健日益向上向好。当前,易特科集团正紧抓战略机遇,大力推进“AI+医疗+健康+养老”建设,积极打造成为全国智慧医疗行业示范点。易特科(前海安测)希望与瑞士银行加深合作共同发展,支持易特科集团早日实现IPO,为更多国人带来更高效、更便捷的医疗健康服务,助力健康中国建设, 实现人类的健康梦,易特科的中国梦!



考察组表示,通过此次考察深入了解,深感易特科集团走在AI医疗创新前沿,各方面工作都保持了健康良好的上升态势,易特科集团发展理念、战略规划科学,发展成绩喜人,前景广阔,吸引了众多政府和银行投资机构密切关注!希望双方能够加速推进全面战略合作,推进易特科(前海安测)的IPO进程,以最先进的人工智能、大数据、深度学习等技术和产品服务于医疗信息化、大健康行业,为健康服务提质增量,共同为健康中国战略实施作出积极贡献!

On December 28th, 2018, Mr. Zou Xingcheng, the deputy director of UBS, led the core team to visit E-Techco (Qianhai AnyCheck) Shenzhen headquarters to inspect AI medical innovation projects and exchange medical information and medical big data applications. Mr. Zhang Guanjing, Chairman and CEO of E-Techco (Qianhai AnyCheck), Vice Chairman Ms. Xiao Yingfen,  Vice President Mr. Wang Hairong, CTO Dr. Ge Xinke, Chief Engineer and General Manager of Investment Department Dr. Gao Weiming, Deputy Chief Engineer Dr. Zhang Hongzhi, Investment The deputy general manager of the department, Mr. Ren Wendong, Senior Sales Manager Mr. Fu Wenzheng and Mr. Zhao Kangfu and other core teams accompanied by the whole team Inspected and explained to Mr. Zou and his team in detail the construction and progress of the E-Techco (Qianhai AnyCheck) AI medical project.

Mr. Zou and his entourage visited the E-Techco Group's product display area and learned about the “Smart Medical Nobel Prize Lab” research project led by Professor Edvard I. Moser and Professor Craig C. Mello. They consulted E-Techco (Qianhai AnyCheck) Health, intelligent, high-end medical care and health construction, and have experienced the information technology products such as AnyCheck Health Smart Integrated Machine, AnyCheck Traditional Chinese Medicine, and self-checking blood pressure, blood glucose and heart rate.

After experiencing the products and services on site, the delegation expressed high recognition for E-Techco Group's planning, layout, research and innovation in the field of medical health, and affirmed the work attitude of project personnel in research and development and innovation.

During the discussion, Chairman Zhang Guanjing mentioned that E-Techco Group, with the support of major banking systems and financial institutions, has comprehensively promoted production management, brand building, intelligent upgrading, and AI medical project construction.  At present, E-Techco Group is firmly grasping strategic opportunities, vigorously promoting the construction of “AI+Medical+Health+Elderly Care” and actively building it into a demonstration point for the national smart medical industry. E-Techco (Qianhai AnyCheck) hope to deepen cooperation with UBS to develop and support E-Techco Group to realize IPO at an early date, bring more efficient and convenient medical and health services to more people, help build China, and realize humanity healthy dreams, E-Techco's Chinese dream.

The inspection team said that through this investigation, we deeply understand that E-Techco Group is at the forefront of AI medical innovation, and all aspects of work have maintained a healthy and good upward trend. E-Techco Group's development philosophy, strategic planning science, and development achievements are gratifying. The prospects are broad, attracting a lot of government and bank investment institutions to pay close attention. It is hoped that both sides can accelerate the promotion of comprehensive strategic cooperation, and provide services such as artificial intelligence, big data, and deep learning to serve the medical informationization and health industry, and improve the quality of health services.